Brief: Portage Biotech Re-Launches Adenosine Unit As Independently Managed Co
06/01/2025 11:23
Jan 6 (Reuters) - Portage Biotech Inc PRTG.O :
* PORTAGE BIOTECH: RE-LAUNCHES ADENOSINE UNIT AS
INDEPENDENTLY
MANAGED CO
* PORTAGE BIOTECH: PETER MOLLOY HAS BEEN APPOINTED CEO OF
UNIT, TO
BE NAMED CYNCADO THERAPEUTICS, INC
Source text: ID:n0001171843-25-000032
Further company coverage: PRTG.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on Alpha Compute
See all newsAlpha Compute Corp expected to post a loss of $3.50 a share - Earnings Preview
NASDAQ RESUMED AT 10:18 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:13 AM
Brief: Alpha Compute Signs Binding Gpu Contract, Leasing ALPHA-03 Cluster Under Four-Year, $81.7 Million Agreement In Its Missouri Superintelligence Factory
Alpha Compute Corp expected to post a loss of $3.50 a share - Earnings Preview